This paper advocates changes in the corporate governance of the World Trade Organization (WTO) to reflect the decline in tariffs and other border restraints to commerce and the emerging challenges of advancing freer trade and better regulation cooperation in a world economy dominated by global...

Many months after COVID-19 vaccines were first authorized for public use, still limited supplies could only partially reduce the devastating loss of life and economic costs caused by the pandemic. Could additional vaccine doses have been manufactured more quickly some other way? Would...

The United States has trade deals with pharmaceutical terms that go beyond the requirements in World Trade Organization (WTO) agreements with 17 countries. Some are more than a decade old, but just two studies have ever assessed how those trade agreements affected prices in practice. This...

Intellectual property rights have long dominated treatment access scholarship and debates, but are at present neither the cause nor the solution for the inaccessibility of treatments for the neglected diseases that afflict the world’s poorest. Prizes and grants have helped stimulate research...

There has been tremendous progress over the last decade in the development of health products for neglected diseases. These include drugs, vaccines, and diagnostics for malaria and tuberculosis, which kill millions of people annually, plus other diseases like chagas and dengue fever, which may...

In 2007, a series of high-profile scandals involving contaminated blood thinner, toxic toothpaste, and melamine-laced pet food demonstrated the threat that unsafe food and drug imports pose to U.S. public health and international trade. Contaminated and adulterated products have sickened and...

Whether the Trans-Pacific Partnership (TPP) talks result in a “high quality, 21st century” trade agreement will depend on its inclusion of new and innovative approaches to persistent trade challenges. Among the new approaches proposed, regulatory coherence appears to have the greatest...

A decade ago, a crisis over access to HIV/AIDS treatment was the catalysis for elevating that disease and the other infectious diseases disproportionately affecting the world’s poor as a foreign policy issue, mobilizing billions in global health aid. Now, a new controversy over patented...